Sort
21,453 grants matching “tuberculosis”
Development of a second generation MDR-XDR TB assay
$538,528David Alland · Rbhs-New Jersey Medical School · U01 · FY2013 · AI
Dissecting functions of IL-23-dependent inflammatory Th17 cells
$538,489Zhiheng He · University Of Southern California · R01 · FY2023 · AI
HIV Infection in Drug Users in Two International Sites
$538,442Sherwood L Gorbach · Tufts University Boston · R01 · FY2008 · DA
Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
$538,429Awewura Jacob Kwara · Miriam Hospital · R01 · FY2013 · HD
Integrated Cost-Effective Point of Care Nucleic Acid Testing for TB diagnosis
$538,394Angelika Niemz · Keck Graduate Inst Of Applied Life Scis · R01 · FY2017 · AI
M. tuberculosis &host gene expression during infection
$538,376Public Health Research Institute · R01 · FY2004 · HL
M. tuberculosis &host gene expression during infection
$538,376Public Health Research Institute · R01 · FY2003 · HL
DIRECTLY ADMINISTERERD HIV THERAPY IN METHADONE CLINICS
$538,341Gregory M Lucas · Johns Hopkins University · R01 · FY2006 · DA
RNA modification and antibiotic resistance
$538,260Graeme L Conn · Emory University · R01 · FY2022 · AI
URBAN ARCH (3/5) Uganda Cohort TB preventive therapy for HIV-infected alcohol users in Uganda: an evaluation of safety tolerability and adherence
$538,240Judith Alissa Hahn · University Of California, San Francisco · U01 · FY2019 · AA
A NON-HUMAN PRIMATE MODEL OF TUBERCULOSIS AND AIDS
$538,200University Of Pittsburgh At Pittsburgh · R01 · FY2002 · AI
International Tuberculosis Research in China
$538,199Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Clinical Core
$538,189Richard Douglas Moore · Johns Hopkins University · P30 · FY2019 · AI
Multi-level and Intersectional Stigma and other Social Determinant Effects on TB Case Detection, Care, and Treatment Outcomes: The MISSED TB Outcomes Study
$538,149Andrew Medina-Marino · Desmond Tutu Hiv Foundation · R01 · FY2022 · AI
Hair Cell Responses to Ototoxic Drugs
$538,119Peter S Steyger · Oregon Health & Science University · R01 · FY2018 · DC
A History of Health in Europe from the Late Paleolithic Era to the Present
$538,118Richard H Steckel · Ohio State University Research Foundation -Do Not Use · · FY2002 · SBE
RNA Vaccine Innovations for TB: Targeting the Mucosa
$538,074Steven G. Reed · Hdt Bio Corporation · R61 · FY2023 · AI
DRUG DESIGN FOR TREATING OPPORTUNISTIC INFECTION IN AIDS
$538,055University Of Houston · R01 · FY2003 · AI
Clinical and immunologic factors underlying heart failure with preserved ejection fraction among persons with HIV in South Africa
$537,987Jason V Baker · Hennepin Healthcare Research Institute · R01 · FY2021 · HL
Cell Migration in Tuberculosis Infection
$537,909Albert Einstein Col Of Med Yeshiva Univ · R01 · FY2004 · HL
A Combination Intervention Package for Isoniazid Preventive Therapy in Ethiopia
$537,707Andrea Howard · Columbia University Health Sciences · R01 · FY2013 · AI
Novel Molecular Modalities for Pharmacological Probe and Therapeutic Lead Discovery
$537,560James Inglese · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR
Investigating (di)terpenoid biosynthesis
$537,153Reuben John Peters · Iowa State University · R35 · FY2020 · GM
Investigating (di)terpenoid biosynthesis
$537,153Reuben John Peters · Iowa State University · R35 · FY2021 · GM
Investigating (di)terpenoid biosynthesis
$537,153Reuben John Peters · Iowa State University · R35 · FY2022 · GM